29 min listen
Alzheimer’s Foundation Head Discusses Breakthroughs: Can Biomarkers & Vaccines Offer Hope?
Alzheimer’s Foundation Head Discusses Breakthroughs: Can Biomarkers & Vaccines Offer Hope?
ratings:
Length:
29 minutes
Released:
Nov 17, 2022
Format:
Podcast episode
Description
Dr. Howard Fillit, the Co-Founder and Chief Science Officer of the Alzheimer’s Drug Discovery Foundation, focuses the nonprofit on supporting scientists around the globe who are investigating novel drugs to prevent, treat and cure Alzheimer’s disease. He explains to hosts Mark Masselli and Margaret Flinter how those investments are paying dividends in terms of diagnostic tools and treatments and why the upcoming holidays are a perfect time to assess if a loved one is showing signs of dementia.
The post Alzheimer’s Foundation Head Discusses Breakthroughs: Can Biomarkers & Vaccines Offer Hope? appeared first on Healthy Communities Online.
The post Alzheimer’s Foundation Head Discusses Breakthroughs: Can Biomarkers & Vaccines Offer Hope? appeared first on Healthy Communities Online.
Released:
Nov 17, 2022
Format:
Podcast episode
Titles in the series (80)
Alzheimer’s Foundation Head Discusses Breakthroughs: Can Biomarkers & Vaccines Offer Hope?: Dr. Howard Fillit, the Co-Founder and Chief Science Officer of the Alzheimer’s Drug Discovery Foundation, focuses the nonprofit on supporting scientists around the globe who are investigating novel drugs to prevent, treat and cure Alzheimer’s disease. by Conversations on Health Care